Table 2.

Comparison of the epitope-specific TCR sequences identified with TCRex to the results from Pogorelyy et al. (2).

Volunteer	Vaccine-associated TCR clones reported by Pogorelyy et al. (2)	Unique canonical vaccine-associated TCRs identified by Pogorelyy et al. (2)	Epitope-specific TCRs identified by TCRex	Overlapping TCRs
P1	1,151	1090	92	2
P2	800	763	110	3
Q1	576	547	79	7
Q2	1,685	1589	92	8
S1	773	747	170	19
S2	983	948	273	11

For each volunteer from Pogorelyy et al. (2) are given: the number of YFV-specific clones (DNA level) reported by the YFV vaccine study, the number of unique canonical YFV-specific TCRs (i.e., TCRs starting with cysteine and ending with phenylalanine) (protein level with CDR3 beta sequences not containing any non-amino acid characters) identified in the YFV vaccine study, the number of epitope-specific sequences in the post-vaccination repertoire identified by TCRex and the number of TCRs identified by both the YFV vaccine study and TCRex.